Global and China Short Bowel Syndrome Drugs Market Insights, Forecast to 2027
SKU ID : QYR-18770536 | Publishing Date : 21-Jul-2021 | No. of pages : 145
Detailed TOC of Global and China Short Bowel Syndrome Drugs Market Insights, Forecast to 2027
1 Study Coverage1.1 Short Bowel Syndrome Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type
1.2.2 Oral Short Bowel Syndrome Drugs
1.2.3 Tablet Short Bowel Syndrome Drugs
1.3 Market by Sale Channel
1.3.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Short Bowel Syndrome Drugs Market Size, Estimates and Forecasts
2.1.1 Global Short Bowel Syndrome Drugs Revenue 2016-2027
2.1.2 Global Short Bowel Syndrome Drugs Sales 2016-2027
2.2 Global Short Bowel Syndrome Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Short Bowel Syndrome Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Short Bowel Syndrome Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Short Bowel Syndrome Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Short Bowel Syndrome Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Short Bowel Syndrome Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Short Bowel Syndrome Drugs Revenue Forecast by Region (2022-2027)
3 Global Short Bowel Syndrome Drugs Competitor Landscape by Players
3.1 Global Top Short Bowel Syndrome Drugs Manufacturers by Sales
3.1.1 Global Short Bowel Syndrome Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Short Bowel Syndrome Drugs Manufacturers by Revenue
3.2.1 Key Short Bowel Syndrome Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Short Bowel Syndrome Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Drugs Revenue in 2020
3.2.6 Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Short Bowel Syndrome Drugs Price by Manufacturers
3.4 Global Short Bowel Syndrome Drugs Manufacturing Base Distribution, Product Types
3.4.1 Short Bowel Syndrome Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Short Bowel Syndrome Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Short Bowel Syndrome Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Short Bowel Syndrome Drugs Market Size by Type (2016-2021)
4.1.1 Global Short Bowel Syndrome Drugs Sales by Type (2016-2021)
4.1.2 Global Short Bowel Syndrome Drugs Revenue by Type (2016-2021)
4.1.3 Short Bowel Syndrome Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Short Bowel Syndrome Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Short Bowel Syndrome Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Short Bowel Syndrome Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Short Bowel Syndrome Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Sale Channel (2016-2027)
5.1 Global Short Bowel Syndrome Drugs Market Size by Sale Channel (2016-2021)
5.1.1 Global Short Bowel Syndrome Drugs Sales by Sale Channel (2016-2021)
5.1.2 Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2016-2021)
5.1.3 Short Bowel Syndrome Drugs Price by Sale Channel (2016-2021)
5.2 Short Bowel Syndrome Drugs Market Size Forecast by Sale Channel (2022-2027)
5.2.1 Global Short Bowel Syndrome Drugs Sales Forecast by Sale Channel (2022-2027)
5.2.2 Global Short Bowel Syndrome Drugs Revenue Forecast by Sale Channel (2022-2027)
5.2.3 Global Short Bowel Syndrome Drugs Price Forecast by Sale Channel (2022-2027)
6 China by Players, Type and Sale Channel
6.1 China Short Bowel Syndrome Drugs Market Size YoY Growth 2016-2027
6.1.1 China Short Bowel Syndrome Drugs Sales YoY Growth 2016-2027
6.1.2 China Short Bowel Syndrome Drugs Revenue YoY Growth 2016-2027
6.1.3 China Short Bowel Syndrome Drugs Market Share in Global Market 2016-2027
6.2 China Short Bowel Syndrome Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Short Bowel Syndrome Drugs Players by Sales (2016-2021)
6.2.2 China Top Short Bowel Syndrome Drugs Players by Revenue (2016-2021)
6.3 China Short Bowel Syndrome Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Short Bowel Syndrome Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Short Bowel Syndrome Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Short Bowel Syndrome Drugs Price by Type (2016-2021)
6.4 China Short Bowel Syndrome Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Short Bowel Syndrome Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Short Bowel Syndrome Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Short Bowel Syndrome Drugs Price Forecast by Type (2022-2027)
6.5 China Short Bowel Syndrome Drugs Historic Market Review by Sale Channel (2016-2021)
6.5.1 China Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2016-2021)
6.5.2 China Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2016-2021)
6.5.3 China Short Bowel Syndrome Drugs Price by Sale Channel (2016-2021)
6.6 China Short Bowel Syndrome Drugs Market Estimates and Forecasts by Sale Channel (2022-2027)
6.6.1 China Short Bowel Syndrome Drugs Sales Forecast by Sale Channel (2022-2027)
6.6.2 China Short Bowel Syndrome Drugs Revenue Forecast by Sale Channel (2022-2027)
6.6.3 China Short Bowel Syndrome Drugs Price Forecast by Sale Channel (2022-2027)
7 North America
7.1 North America Short Bowel Syndrome Drugs Market Size YoY Growth 2016-2027
7.2 North America Short Bowel Syndrome Drugs Market Facts & Figures by Country
7.2.1 North America Short Bowel Syndrome Drugs Sales by Country (2016-2021)
7.2.2 North America Short Bowel Syndrome Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Short Bowel Syndrome Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Short Bowel Syndrome Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Short Bowel Syndrome Drugs Market Size YoY Growth 2016-2027
9.2 Europe Short Bowel Syndrome Drugs Market Facts & Figures by Country
9.2.1 Europe Short Bowel Syndrome Drugs Sales by Country (2016-2021)
9.2.2 Europe Short Bowel Syndrome Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Short Bowel Syndrome Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Short Bowel Syndrome Drugs Market Facts & Figures by Country
10.2.1 Latin America Short Bowel Syndrome Drugs Sales by Country (2016-2021)
10.2.2 Latin America Short Bowel Syndrome Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Short Bowel Syndrome Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Short Bowel Syndrome Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Emmaus Medical
12.1.1 Emmaus Medical Corporation Information
12.1.2 Emmaus Medical Description and Business Overview
12.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Emmaus Medical Short Bowel Syndrome Drugs Products Offered
12.1.5 Emmaus Medical Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Short Bowel Syndrome Drugs Products Offered
12.2.5 Merck Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Description and Business Overview
12.3.3 Takeda Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Short Bowel Syndrome Drugs Products Offered
12.3.5 Takeda Recent Development
12.4 Ardelyx
12.4.1 Ardelyx Corporation Information
12.4.2 Ardelyx Description and Business Overview
12.4.3 Ardelyx Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ardelyx Short Bowel Syndrome Drugs Products Offered
12.4.5 Ardelyx Recent Development
12.5 Naia Pharmaceuticals
12.5.1 Naia Pharmaceuticals Corporation Information
12.5.2 Naia Pharmaceuticals Description and Business Overview
12.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Products Offered
12.5.5 Naia Pharmaceuticals Recent Development
12.6 Nutrinia
12.6.1 Nutrinia Corporation Information
12.6.2 Nutrinia Description and Business Overview
12.6.3 Nutrinia Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Nutrinia Short Bowel Syndrome Drugs Products Offered
12.6.5 Nutrinia Recent Development
12.7 OxThera
12.7.1 OxThera Corporation Information
12.7.2 OxThera Description and Business Overview
12.7.3 OxThera Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 OxThera Short Bowel Syndrome Drugs Products Offered
12.7.5 OxThera Recent Development
12.8 GLyPharma Therapeutic
12.8.1 GLyPharma Therapeutic Corporation Information
12.8.2 GLyPharma Therapeutic Description and Business Overview
12.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Products Offered
12.8.5 GLyPharma Therapeutic Recent Development
12.9 Sancilio Pharmaceuticals
12.9.1 Sancilio Pharmaceuticals Corporation Information
12.9.2 Sancilio Pharmaceuticals Description and Business Overview
12.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Products Offered
12.9.5 Sancilio Pharmaceuticals Recent Development
12.10 Zealand Pharma
12.10.1 Zealand Pharma Corporation Information
12.10.2 Zealand Pharma Description and Business Overview
12.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Zealand Pharma Short Bowel Syndrome Drugs Products Offered
12.10.5 Zealand Pharma Recent Development
12.11 Emmaus Medical
12.11.1 Emmaus Medical Corporation Information
12.11.2 Emmaus Medical Description and Business Overview
12.11.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Emmaus Medical Short Bowel Syndrome Drugs Products Offered
12.11.5 Emmaus Medical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Short Bowel Syndrome Drugs Industry Trends
13.2 Short Bowel Syndrome Drugs Market Drivers
13.3 Short Bowel Syndrome Drugs Market Challenges
13.4 Short Bowel Syndrome Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Short Bowel Syndrome Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and China Short Bowel Syndrome Drugs Market Insights, Forecast to 2027
List of TablesTable 1. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Oral Short Bowel Syndrome Drugs
Table 3. Major Manufacturers of Tablet Short Bowel Syndrome Drugs
Table 4. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel (2021-2027) & (K Pcs)
Table 5. Global Short Bowel Syndrome Drugs Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Short Bowel Syndrome Drugs Sales by Regions (2016-2021) & (K Pcs)
Table 7. Global Short Bowel Syndrome Drugs Sales Market Share by Regions (2016-2021)
Table 8. Global Short Bowel Syndrome Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Short Bowel Syndrome Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 10. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Short Bowel Syndrome Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Short Bowel Syndrome Drugs Sales by Manufacturers (2016-2021) (K Pcs)
Table 14. Global Short Bowel Syndrome Drugs Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Short Bowel Syndrome Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 16. Short Bowel Syndrome Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2016-2021)
Table 18. Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Short Bowel Syndrome Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome Drugs as of 2020)
Table 20. Key Manufacturers Short Bowel Syndrome Drugs Price (2016-2021) (USD/Pcs)
Table 21. Short Bowel Syndrome Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Short Bowel Syndrome Drugs Product Type
Table 23. Date of International Manufacturers Enter into Short Bowel Syndrome Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Short Bowel Syndrome Drugs Sales by Type (2016-2021) (K Pcs)
Table 26. Global Short Bowel Syndrome Drugs Sales Share by Type (2016-2021)
Table 27. Global Short Bowel Syndrome Drugs Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Short Bowel Syndrome Drugs Revenue Share by Type (2016-2021)
Table 29. Short Bowel Syndrome Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 30. Global Short Bowel Syndrome Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 31. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Short Bowel Syndrome Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Short Bowel Syndrome Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 35. Global Short Bowel Syndrome Drugs Sales by Sale Channel (2016-2021) (K Pcs)
Table 36. Global Short Bowel Syndrome Drugs Sales Share by Sale Channel (2016-2021)
Table 37. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2016-2021) (US$ Million)
Table 38. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2016-2021)
Table 39. Short Bowel Syndrome Drugs Average Selling Price (ASP) by Sale Channel (2016-2021) & (USD/Pcs)
Table 40. Global Short Bowel Syndrome Drugs Sales Forecast by Sale Channel (2022-2027) & (K Pcs)
Table 41. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Sale Channel (2022-2027)
Table 42. Global Short Bowel Syndrome Drugs Revenue Forecast by Sale Channel (2022-2027) & (US$ Million)
Table 43. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Sale Channel (2022-2027)
Table 44. Global Short Bowel Syndrome Drugs Average Selling Price (ASP) Forecast by Sale Channel (2022-2027) & (USD/Pcs)
Table 45. China Short Bowel Syndrome Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 46. China Short Bowel Syndrome Drugs Sales Share by Company (2016-2021)
Table 47. China Short Bowel Syndrome Drugs Revenue (US$ Million) by Company (2016-2021)
Table 48. China Short Bowel Syndrome Drugs Revenue Share by Company (2016-2021)
Table 49. China Short Bowel Syndrome Drugs Sales (K Pcs) by Type (2016-2021)
Table 50. China Short Bowel Syndrome Drugs Sales Share by Type (2016-2021)
Table 51. China Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Short Bowel Syndrome Drugs Price (USD/Pcs) by Type (2016-2021)
Table 53. China Short Bowel Syndrome Drugs Sales (K Pcs) by Type (2022-2027)
Table 54. China Short Bowel Syndrome Drugs Sales Share by Type (2022-2027)
Table 55. China Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Short Bowel Syndrome Drugs Revenue Share by Type (2022-2027)
Table 57. China Short Bowel Syndrome Drugs Price (USD/Pcs) by Type (2022-2027)
Table 58. China Short Bowel Syndrome Drugs Sales (K Pcs) by Sale Channel (2016-2021)
Table 59. China Short Bowel Syndrome Drugs Sales Share by Sale Channel (2016-2021)
Table 60. China Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Sale Channel (2016-2021)
Table 61. China Short Bowel Syndrome Drugs Price (USD/Pcs) by Sale Channel (2016-2021)
Table 62. China Short Bowel Syndrome Drugs Sales (K Pcs) by Sale Channel (2022-2027)
Table 63. China Short Bowel Syndrome Drugs Sales Share by Sale Channel (2022-2027)
Table 64. China Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Sale Channel (2022-2027)
Table 65. China Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2022-2027)
Table 66. China Short Bowel Syndrome Drugs Price (USD/Pcs) by Sale Channel (2022-2027)
Table 67. North America Short Bowel Syndrome Drugs Sales by Country (2016-2021) & (K Pcs)
Table 68. North America Short Bowel Syndrome Drugs Sales Market Share by Country (2016-2021)
Table 69. North America Short Bowel Syndrome Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Short Bowel Syndrome Drugs Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2016-2021) & (K Pcs)
Table 72. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Short Bowel Syndrome Drugs Revenue Market Share by Region (2016-2021)
Table 75. Europe Short Bowel Syndrome Drugs Sales by Country (2016-2021) & (K Pcs)
Table 76. Europe Short Bowel Syndrome Drugs Sales Market Share by Country (2016-2021)
Table 77. Europe Short Bowel Syndrome Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Short Bowel Syndrome Drugs Revenue Market Share by Country (2016-2021)
Table 79. Latin America Short Bowel Syndrome Drugs Sales by Country (2016-2021) & (K Pcs)
Table 80. Latin America Short Bowel Syndrome Drugs Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Short Bowel Syndrome Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Short Bowel Syndrome Drugs Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2016-2021) & (K Pcs)
Table 84. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Short Bowel Syndrome Drugs Revenue Market Share by Country (2016-2021)
Table 87. Emmaus Medical Corporation Information
Table 88. Emmaus Medical Description and Business Overview
Table 89. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 90. Emmaus Medical Short Bowel Syndrome Drugs Product
Table 91. Emmaus Medical Recent Development
Table 92. Merck Corporation Information
Table 93. Merck Description and Business Overview
Table 94. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 95. Merck Product
Table 96. Merck Recent Development
Table 97. Takeda Corporation Information
Table 98. Takeda Description and Business Overview
Table 99. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 100. Takeda Product
Table 101. Takeda Recent Development
Table 102. Ardelyx Corporation Information
Table 103. Ardelyx Description and Business Overview
Table 104. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 105. Ardelyx Product
Table 106. Ardelyx Recent Development
Table 107. Naia Pharmaceuticals Corporation Information
Table 108. Naia Pharmaceuticals Description and Business Overview
Table 109. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 110. Naia Pharmaceuticals Product
Table 111. Naia Pharmaceuticals Recent Development
Table 112. Nutrinia Corporation Information
Table 113. Nutrinia Description and Business Overview
Table 114. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 115. Nutrinia Product
Table 116. Nutrinia Recent Development
Table 117. OxThera Corporation Information
Table 118. OxThera Description and Business Overview
Table 119. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 120. OxThera Product
Table 121. OxThera Recent Development
Table 122. GLyPharma Therapeutic Corporation Information
Table 123. GLyPharma Therapeutic Description and Business Overview
Table 124. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 125. GLyPharma Therapeutic Product
Table 126. GLyPharma Therapeutic Recent Development
Table 127. Sancilio Pharmaceuticals Corporation Information
Table 128. Sancilio Pharmaceuticals Description and Business Overview
Table 129. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 130. Sancilio Pharmaceuticals Product
Table 131. Sancilio Pharmaceuticals Recent Development
Table 132. Zealand Pharma Corporation Information
Table 133. Zealand Pharma Description and Business Overview
Table 134. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 135. Zealand Pharma Product
Table 136. Zealand Pharma Recent Development
Table 137. Short Bowel Syndrome Drugs Market Trends
Table 138. Short Bowel Syndrome Drugs Market Drivers
Table 139. Short Bowel Syndrome Drugs Market Challenges
Table 140. Short Bowel Syndrome Drugs Market Restraints
Table 141. Short Bowel Syndrome Drugs Customers List
Table 142. Short Bowel Syndrome Drugs Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Bowel Syndrome Drugs Product Picture
Figure 2. Global Short Bowel Syndrome Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Oral Short Bowel Syndrome Drugs Product Picture
Figure 4. Tablet Short Bowel Syndrome Drugs Product Picture
Figure 5. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel in 2020 & 2027
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Short Bowel Syndrome Drugs Report Years Considered
Figure 10. Global Short Bowel Syndrome Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Short Bowel Syndrome Drugs Market Size 2016-2027 (US$ Million)
Figure 12. Global Short Bowel Syndrome Drugs Sales 2016-2027 (K Pcs)
Figure 13. Global Short Bowel Syndrome Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2016-2021)
Figure 15. Global Short Bowel Syndrome Drugs Sales Market Share by Region in 2020
Figure 16. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2016-2021)
Figure 17. Global Short Bowel Syndrome Drugs Revenue Market Share by Region in 2020
Figure 18. Global Short Bowel Syndrome Drugs Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Short Bowel Syndrome Drugs Revenue in 2020
Figure 20. Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2016-2021)
Figure 22. Global Short Bowel Syndrome Drugs Sales Market Share by Type in 2020
Figure 23. Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Short Bowel Syndrome Drugs Revenue Market Share by Type in 2020
Figure 25. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2016-2021)
Figure 26. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel in 2020
Figure 27. Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2016-2021)
Figure 28. Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel in 2020
Figure 29. China Short Bowel Syndrome Drugs Sales Growth Rate 2016-2027 (K Pcs)
Figure 30. China Short Bowel Syndrome Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Short Bowel Syndrome Drugs Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Short Bowel Syndrome Drugs Players Market Share by Revenue in Short Bowel Syndrome Drugs in 2020
Figure 33. China Short Bowel Syndrome Drugs Revenue Share by Type (2016-2021)
Figure 34. China Short Bowel Syndrome Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2016-2021)
Figure 36. China Short Bowel Syndrome Drugs Revenue Growth Rate by Sale Channel in 2016 & 2020
Figure 37. North America Short Bowel Syndrome Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 38. North America Short Bowel Syndrome Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Short Bowel Syndrome Drugs Sales Market Share by Country in 2020
Figure 40. North America Short Bowel Syndrome Drugs Revenue Market Share by Country in 2020
Figure 41. U.S. Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 42. U.S. Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 44. Canada Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Short Bowel Syndrome Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 46. Europe Short Bowel Syndrome Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Short Bowel Syndrome Drugs Sales Market Share by Country in 2020
Figure 48. Europe Short Bowel Syndrome Drugs Revenue Market Share by Country in 2020
Figure 49. Germany Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 50. Germany Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 52. France Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. U.K. Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. Italy Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. Russia Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Short Bowel Syndrome Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 60. Asia Pacific Short Bowel Syndrome Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Region in 2020
Figure 62. Asia Pacific Short Bowel Syndrome Drugs Revenue Market Share by Region in 2020
Figure 63. China Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 64. China Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 66. Japan Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. South Korea Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. India Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. Australia Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. China Taiwan Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. Indonesia Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Thailand Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Malaysia Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Short Bowel Syndrome Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 82. Latin America Short Bowel Syndrome Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Short Bowel Syndrome Drugs Sales Market Share by Country in 2020
Figure 84. Latin America Short Bowel Syndrome Drugs Revenue Market Share by Country in 2020
Figure 85. Mexico Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Mexico Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 88. Brazil Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 90. Argentina Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Middle East and Africa Short Bowel Syndrome Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 92. Middle East and Africa Short Bowel Syndrome Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Country in 2020
Figure 94. Middle East and Africa Short Bowel Syndrome Drugs Revenue Market Share by Country in 2020
Figure 95. Turkey Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 96. Turkey Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Saudi Arabia Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 98. Saudi Arabia Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. UAE Short Bowel Syndrome Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 100. UAE Short Bowel Syndrome Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Short Bowel Syndrome Drugs Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
Keyplayers in Global and China Short Bowel Syndrome Drugs Market Insights, Forecast to 2027
Emmaus MedicalMerck
Takeda
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
GLyPharma Therapeutic
Sancilio Pharmaceuticals
Zealand Pharma